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Human mesenchymal stem cell-
engineered hepatic cell sheets 
accelerate liver regeneration in 
mice
Noriko Itaba1,*, Yoshiaki Matsumi1,*, Kaori Okinaka1, An Afida Ashla1, Yohei Kono1, 
Mitsuhiko Osaki2, Minoru Morimoto3, Naoyuki Sugiyama4, Kazuo Ohashi5, Teruo Okano6 & 
Goshi Shiota1
Mesenchymal stem cells (MSCs) are an attractive cell source for cell therapy. Based on our hypothesis 
that suppression of Wnt/β-catenin signal enhances hepatic differentiation of human MSCs, we 
developed human mesenchymal stem cell-engineered hepatic cell sheets by a small molecule 
compound. Screening of 10 small molecule compounds was performed by WST assay, TCF reporter 
assay, and albumin mRNA expression. Consequently, hexachlorophene suppressed TCF reporter 
activity in time- and concentration-dependent manner. Hexachlorophene rapidly induced hepatic 
differentiation of human MSCs judging from expression of liver-specific genes and proteins, PAS 
staining, and urea production. The effect of orthotopic transplantation of human mesenchymal stem 
cell-engineered hepatic cell sheets against acute liver injury was examined in one-layered to three-
layered cell sheets system. Transplantation of human mesenchymal stem cell-engineered hepatic cell 
sheets enhanced liver regeneration and suppressed liver injury. The survival rates of the mice were 
significantly improved. High expression of complement C3 and its downstream signals including C5a, 
NF-κB, and IL-6/STAT-3 pathway was observed in hepatic cell sheets-grafted tissues. Expression of 
phosphorylated EGFR and thioredoxin is enhanced, resulting in reduction of oxidative stress. These 
findings suggest that orthotopic transplantation of hepatic cell sheets manufactured from MSCs 
accelerates liver regeneration through complement C3, EGFR and thioredoxin.
The liver has a regenerative capacity in response to acute liver injury, however, severe liver damage some-
times threatens life, and in these cases liver transplantation is required. Orthotopic liver transplantation 
(OLT) is the appropriate therapy for liver failure, but harbors the problems of organ shortage and com-
plications associated with rejection and immunosuppression1,2. Cell therapy has a potential of alternative 
therapy to OLT3, and various types of cells including mesenchymal stem cells (MSCs) are studied to 
be applied as cell therapy for liver failure4–10. Humoral factors from MSCs as well as transplantation of 
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MSCs ameliorated acute and chronic liver failure2,8,11–13. MSCs are an optimal cell source for cell therapy 
in the clinical settings.
We previously reported that Wnt/β -catenin signaling was suppressed during hepatic differentia-
tion process of human MSCs14,15. In addition, knockdown of signaling molecules or target genes of 
Wnt/β -catenin signals resulted in hepatic differentiation of human MSCs. Bone marrow-derived MSCs 
(BM-MSCs) were able to differentiate into hepatocytes in the presence of Dkk-116. Taken together, sup-
pression of Wnt/β -catenin signal plays an important role in hepatic differentiation of MSCs. In the pres-
ent study, we identified a small molecule compound that efficiently induces hepatic differentiation of 
human MSCs, since the use of small molecule compounds is a safe way, providing an advantage over 
using cytokines, nucleic acids or protein drug products17.
We manufactured hepatic cell sheets derived from MSCs for treatment of liver failure because cell 
sheet engineering enabled tissues to retain hepatic functions compared to isolated cell transplantation18. 
This technology enabled us to manufacture the two- and three dimensional functional cell sheets and 
transplant into the desired sites of the body by minimum invasive procedure19. We examined the thera-
peutic effects of hepatic cell sheets for acute liver injury in mice.
Results
Identification of inhibitors of Wnt/β-catenin signaling of MSCs. We previously reported that sup-
pression of Wnt/β -catenin signal by siRNA enhanced hepatic differentiation of human bone marrow-de-
rived MSCs and umbilical cord-derived MSCs14,15. In the present study, we focused on ten small molecule 
compounds including CGP049090, PKF115-584, PKF118-310, PNU-74654, ICG-001, NSC668036, 
quercetin, ionomycin, imatinib, and hexachlorophene20–23, most of which inhibited Wnt/β -catenin sig-
nal in colon cancer cells. To assess the effect of Wnt/β -catenin signal, we carried out reporter assay using 
the E7-TCF4 cells, which are the UE7T-13 cells stably expressed firefly luciferase gene under the con-
trol of the TCF-4 motif. Nine compounds except for NSC668036 inhibited Wnt/β -catenin transcription 
activities (Supplementary Fig. 1). Of these, hexachlorophene most potently suppressed TCF4/β -catenin 
transcriptional activity in a time- and concentration-dependent manner (Fig.  1a). Hexachlorophene at 
0.8–1.6 μ M had little effect on cell viabilities (Supplementary Fig. 2). Hexachlorophene also exhibited 
suppressive effects on TCF4/β -catenin transcriptional activity in a concentration-dependent manner of 
human bone marrow mononuclear cells obtained from a patient with osteoarthritis under informed 
consent (Supplementary Fig. 3).
Effect of hexachlorophene on hepatic differentiation of human MSCs. To investigate the effect 
on hepatic differentiation, albumin mRNA was examined after treatment with 9 each compound in 
UE7T-13 cells. Hexachlorophene potently induced albumin mRNA, but the other compounds did not 
(data not shown). Hexachlorophene enhanced expression of liver-specific genes including albumin, com-
plement C3, C4, apolipoprotein E, and α 1-antitrypsin, and decreased expression of stem cell markers 
including nanog and N-cadherin except for vimentin (Fig.  1b). Inducible effects of albumin, C4, and 
apolipoprotein E were also observed by 0.1% DMSO treatment. The effect of DMSO has been reported 
to induce hepatic differentiation of MSCs24, however, treatment with 0.8 μ M hexachlorophene induced 
hepatic gene expression more potently than DMSO treatment. Complement C3 was prominently induced 
by 0.8 μ M hexachlorophene treatment. Hexachlorophene-treated cells expressed hepatocyte-specific pro-
teins including albumin and C/EBPα on day 8 (Fig.  1c). Around 40% of the cells treated with 0.8 μ M 
hexachlorophene expressed albumin and C/EBPα on day 8, respectively (Fig.  1d). Correspondingly, 
characteristic glycogen granules were observed in cytoplasm of the cells on day 8 (Fig. 1e). Urea produc-
tion was significantly increased in hexachlorophene-treated cells on day 8, which is comparable to that 
of Huh7 cells (Fig. 1f). Although liver functions of Huh7 cells are not so high as primary hepatocytes, 
it was clearly shown that hexachlorophene treatment certainly committed MSCs toward hepatic lineage. 
Besides UE7T-13 cells, the CD90+ CD271+ primary human bone marrow mononuclear cells obtained 
from a osteoarthritis patient exhibited liver function such as glycogen synthesis and urea production 
after treatment with hexachlorophene for 8 days (Supplementary Fig. 4). These findings suggest that 
hexachlorophene rapidly induces hepatic differentiation of of human BM-MSCs.
Since hexachlorophene promoted β -catenin degradation via proteasome25, the effect of hexachloro-
phene on UE7T-13 cells was examined. Whereas treatment with hexachlorophene led to reduction in 
β -catenin and cyclin D1, the effect of hexachlorophene was abolished by MG-132, a proteasome inhibitor 
(Supplementary Fig. 5). These data indicate that hexachlorophene inhibits Wnt/β -catenin signaling via 
degradation of intracellular β -catenin in a proteasome-dependent fashion.
Hexachlorophene-induced hepatic cell sheets ameliorated acute liver injury in mice. To clar-
ify the therapeutic effect of hepatic cell sheets, transplantable cell sheets were manufactured by treat-
ing UE7T-13 BM-MSCs with hexachlorophene on thermo-responsive polymer coated culture dishes. 
Although the utility of hepatic tissue sheets has been shown by heterotopic transplantation18, ortho-
topic transplantation was performed to obtain direct effects of hepatic cell sheets. The cell sheets were 
transplanted onto two sites of the left lateral liver lobe, in 1-layered, 2-layered, and 3-layered dimen-
sional fashion. At 24 hours after transplantation, mice were received carbon tetrachloride by oral gav-
age. Although normal murine liver without carbon tetrachloride intoxication showed a smooth and 
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soft surface, sham-operated mice livers with carbon tetrachloride intoxication exhibited white multifocal 
granular accumulations on day 8 (Fig. 2a). However, white multifocal granular accumulations improved 
in cell sheets number-dependent fashion. All the transplanted groups showed acceleration of body weight 
Figure 1. Suppression of Wnt/β-catenin signaling with hexachlorophene induced hepatic specification 
of MSCs. (a) TCF4/β -catenin reporter assay was performed on day 1, 4, and 8 after addition of 
hexachlorophene. Data are expressed as the mean ± SE of 8 separate wells. *p < 0.05, **p < 0.01, 
compared to vehicle examined by student’s t-test. (b) Effect of hexachlorophene on gene expression was 
determined on day 8 by RT-PCR analysis. (c) Expression of albumin and C/EBPα protein was evaluated 
by immunofluorescence. Huh7 cells were used as a positive control. (d) The percentages of albumin- and 
C/EBPα - positive cells were evaluated by immunofluorescence. Data are expressed as the mean ± SE of 5 
randomly selected fields. *p < 0.05, **p < 0.01, compared to vehicle examined by student’s t-test. (e) PAS 
staining was performed on day 0 and day 8. (f) Urea production was determined by urea assay on day 8. 
*p < 0.05, **p < 0.01, compared to vehicle, respectively, examined by student’s t-test.
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recovery from the reduction caused by CCl4 (Supplementary Fig. 6). Indeed, liver/body weight on day 
8 was lower in transplanted mice than in sham-operated group (Fig. 2b). The survival rates of the mice, 
which received 2- and 3-layered cell sheets, were significantly improved compared to sham-operated 
mice (Fig. 2c). On day 2 after transplantation, serum alanine aminotransferase (ALT) was improved in 
Figure 2. Transplantation of hepatic cell sheets ameliorated acute liver injury. (a) Gross appearances of 
livers from sham-operated and cell sheets-transplanted mice on day 8. CCl4(−) represents normal mouse 
liver without carbon tetrachloride intoxication. Scale bar = 10 mm. (b) Liver weight (left panel) and liver/
body weight (right panel) on day 8 after transplantation. Data are expressed as mean ± SE (n = 8–10 each 
except n = 3 for CCl4(− )). *p < 0.05, **p < 0.01, compared to sham-operated mice examined by Games-
Howell test. (c) Survival rate after transplantation (n = 18–20 in each group). *p < 0.05, compared to sham-
operated mice and examined by Log-rank test. (d) Serum ALT on day 2, 4, and 8 after transplantation.  
(e) Serum AST on day 2, 4, and 8 after transplantation. (f) Serum bilirubin on day 2. Data are expressed 
as mean ± SE (n = 8–10 on each day). *p < 0.05, **p < 0.01, compared to sham-operated mice examined by 
Games-Howell test.
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transplanted groups compared to sham-operated group in cell sheets number-dependent manner. Serum 
aspartate aminotransferase (AST) was also decreased in the transplanted groups (Fig. 2d,e). All the trans-
planted groups showed marked reduction in serum bilirubin on day 2 in cell sheets number-dependent 
fashion (Fig. 2f). These data suggest that transplantation of hepatic cell sheets has preventive effects on 
acute liver injury induced by CCl4 administration.
In addition, the therapeutic effects of hepatic cell sheets on acute liver injury were examined in the 
experiments where hepatic cells sheets were transplanted onto mouse liver at 6 h after CCl4 adminis-
tration (Fig.  3). Serum ALT and AST were significantly lower in the 3-layered cell sheets-transplanted 
mice than sham-operated mice on 1 and 2 days after CCl4 treatment (Fig. 3a,b). Total bilirubin was also 
decreased in the 3-layered cell sheets-transplanted mice in comparison with the sham-operated mice on 
day 1 (Fig. 3c). These data suggest that human mesenchymal stem cell-engineered hepatic cell sheets have 
therapeutic effects on acute liver injury as well as preventive effects.
We examined the details of liver injury in the model where transplantation of hepatic cell sheets was 
performed and then CCl4 was administered on the next day as the follows. Hepatic necrosis diffusely 
occurred in sham-operated mice on day 2, and was gradually reduced up to day 8 (Fig. 4a). However, 
necrotic areas in liver of 3-layered cell sheets-transplanted mice showed remarkable recovery on day 2, 3, 
Figure 3. Biochemical tests of initial CCl4 liver injury predated hepatic cell sheets transplantation. At 
six hours after CCl4 administration, mice were received hepatic cell sheets onto the livers. (a) Serum ALT  
on day 1, 2, and 3 after CCl4 administration. (b) Serum AST on day 1, 2, and 3 after CCl4 administration.  
(c) Total bilirubin on day 1 after CCl4 administration. Data are expressed as mean ± SE (n = 9–10 on each 
day). *p < 0.05, **p < 0.01, compared with sham-operated mice (Mann-Whitney U-test).
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4, and 8, compared to sham-operated mice (Fig. 4b). These data indicate that transplantation of hepatic 
cell sheets potently ameliorates acute liver injury.
Hepatic cell sheets promoted liver regeneration. To clarify the mechanisms of ameliorat-
ing liver injury by hepatic cell sheets, proliferation of hepatocytes was assessed in both 3-layered cell 
Figure 4. Hepatic cell sheets accelerated liver regeneration. (a) Hematoxylin and eosin staining of native 
livers of sham-operated and 3-layered cell sheets transplanted mice on day 3, 4, and 8. Scale bar = 20 μ m. 
(b) Gradual decreases of necrotic areas. Data are expressed as mean ± SE. 5 fields of each individual mice 
were measured (n = 5–6). *p < 0.05, **p < 0.01, examined by Mann-Whitney U-test. (c) The Ki-67-positive 
hepatocytes of native livers determined by immunohistochemistry. The brown-stained nuclei indicate the 
positivity for Ki-67. Scale bar = 20 μ m. Sham and 3-layered sheets represent liver of sham-operated mice 
and 3-layered hepatic cell sheets-transplanted liver, respectively. (d) The bars show the percentages of Ki-67-
positive hepatocytes. Data are expressed as mean ± SE (n = 6, 5 fields of individual mice were measured). 
*p < 0.05, **p < 0.01, examined by Mann-Whitney U-test. (e) Mitotic cells of native livers are shown as 
arrows on day 4. Scale bar = 20 μ m. (f) The bars show the mitotic cells which are expressed as mean ± SE 
(n = 6). 5 fields per individual mice were measured. *P < 0.05, examined by Mann-Whitney U-test.
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sheets-transplanted and sham-operated livers in the model where transplantation of hepatic cell sheets 
was performed and then CCl4 was administered on the next day. The Ki-67-positive hepatocytes were not 
observed in the livers of both mice on day 2. However, the Ki-67-positive hepatocytes were dramatically 
increased in hepatic cell sheets-transplanted mice on day 3 and 4 (Fig. 4c). The positive rates of Ki-67 
cells were significantly higher in hepatic cell sheets-transplanted mice than the sham-operated mice 
(Fig. 4d). The mitosis of hepatocytes actively occurred on day 4. (Fig. 4e). The percentages of mitotic cells 
in cell sheets-transplanted mice were significantly increased on day 4 in hepatic cell sheets-transplanted 
mice (Fig. 4f). These data suggest that transplantation of hepatic cell sheets directly promotes liver regen-
eration via some humoral factors.
Since several humoral factors secreted from MSCs improved hepatotoxin-induced hepatic 
injury11,12, we clarified whether these therapeutic effects were originated from MSCs per se or acquired 
hepatic functions via hepatic differentiation by hexachlorophene. To clarify this issue, therapeutic 
effects on liver damages were compared between hexachlorophene-treated cell sheets-transplanted 
and non-treated BM-MSCs-derived cell sheets-transplanted mice. The recovery of body weight in 
the hexachlorophene-treated cell sheets-transplanted mice was much faster than in non-treated 
BM-MSCs-derived cell sheets-transplanted mice (Fig. 5a). Significant reduction in liver/body weight on 
day 8 was also observed in the hexachlorophene-treated cell sheets-transplanted mice (Fig. 5b). Although 
serum ALT levels in both groups were lower than sham group on day 2, it was significantly lower in 
hexachlorophene-treated cell sheets mice than non-treated BM-MSCs sheets mice on day 4 (Fig.  5c). 
Serum AST was also significantly decreased in both groups, compared to sham-operated group on day 
2, but no changes were observed between two groups on day 4. However, on day 8, serum AST was sig-
nificantly lower in hexachlorophene-treated cell sheets group than sham-operated group (Fig. 5d). Serum 
bilirubin was lower in both the cell sheets transplanted groups than sham-operated group at day 2, but 
there was no difference between the groups (Fig. 5e). The survival rate was improved by treatment with 
hexachlorophene, but not significantly (Supplementary Fig. 7). These data suggest that hepatic differen-
tiation obtained by hexachlorophene provides cell sheets with potent regenerative abilities.
Complement C3 promotes IL6-STAT3 pathway through NF-κB activation. To further clar-
ity the cause of liver regeneration, we focused on serum proteins which were secreted by hepatic cell 
sheets. Expression of various human liver-specific genes including albumin, α 1-antitrypsin, apolipopro-
tein E, and complement C3 and C4 was examined in the grafted tissues (Fig. 6a). Among them, expres-
sion of albumin, ceruloplasmin, and apolipoprotein E was decreased with time. The hematoxylin and 
eosin staining of the grafted cell sheets on day 8 showed that many cells were still stained with eosin, 
however, the morphologies of many cells were fibroblastic, like MSCs (Supplementary Fig. 8). Taken 
together, some transdifferentiated cells might dedifferentiate into MSCs. Taking into consideration that 
hexachlorophene-induced hepatic cell sheets are superior to BM-MSCs sheets, we focused on comple-
ment C3, which was intensively expressed from day 2 to 8 (Fig. 6a). Although complement C3 is known 
to play a role in the immune system, it is also involved in the early priming stages of liver regeneration 
after partial hepatectomy26. Consequently, expression of C5a, a downstream pathway of complement C3, 
was increased in livers of hepatic cell sheets-transplanted mice on day 2 and 4 (Fig.  6b). Complement 
C3a and C5a are known to activate NF-κ B through binding G-protein coupled receptors C3aR and 
C5aR on Kupffer cells, respectively5. If C5a bound to C5aR on hepatocyte, the priming of hepatocyte 
in liver regeneration is promoted. On day 2, in accordance with increased expression of C5a, NF-κ B 
was translocated to the nuclei of hepatocytes of 3-layered cell sheets-transplanted livers (Fig.  6c). The 
positive rates of nuclear NF-κ B in hepatocytes of 3-layered cell sheets-transplanted livers were increased 
by 7-fold (Fig.  6d). IL-6 mRNA, a target gene of NF-κ B, was upregulated in cell sheets-transplanted 
livers on day 2 (Fig. 6e). IL-6 protein was also increased in cell sheets-transplanted livers from day 2 to 
4 (Supplementary Fig. 9a). The IL-6-positive hepatocytes were observed in close proximity to grafted 
cell sheets on day 2 (Supplementary Fig. 9b). IL6 acts as a priming factor of liver regeneration through 
binding IL-6R/gp130 receptor complex followed by STAT3 activation27,28. Phosphorylation of gp130 was 
observed on day 2 and 3 (data not shown), and STAT3 was intensely phosphorylated from day 2 to 4 
in transplanted liver (Fig.  6f). Interestingly, the Ki-67-positive hepatocytes were observed beneath the 
grafted cell sheets on day 2 (Supplementary Fig. 9b), where the IL-6-positive hepatocytes also similarly 
distributed. These findings are in sharp contrast to those of Fig. 4c, where the Ki-67-positive hepatocytes 
were not observed in the livers inside that the distance left from the surface on day 2. Taken together, 
these data suggest that complement C3 secreted from hepatic cell sheets activated IL-6/STAT-3 pathway 
via C5-mediated nuclear translocation of NF-κ B.
Role of other cytokines secreted from hepatic cell sheets in liver regeneration. Although 
hepatic differentiation provides cell sheets with potent regenerative abilities, expression of various 
cytokines which MSCs originally harbor was also examined in grafted tissues of cell sheets. In the grafted 
tissues, various human-specific gene expression of MSC-related cytokines such as TNFα , amphiregulin, 
TGFα , HGF, SCF, FGF2, VEGFα , angiopoietin, and angiogenin was observed (Fig.  7a). To clarify the 
cytokines involved in this system, downstream signals of these factors in murine liver tissues were exam-
ined. Phosphorylation of c-kit as the priming factor of liver regeneration27 was slightly detected in hepatic 
cell sheets-transplanted mice on day 2 (Fig. 7b). HGF and EGF receptor (EGFR) ligands are important 
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Figure 5. Effects of hepatic differentiated MSCs-derived cell sheets were superior to those of non-
differentiated MSCs. (a) The changes of body weights of sham-operated, non-induced MSCs transplanted, 
and hexachlorophene-induced MSCs transplanted mice in acute liver injury model. Data are expressed as 
mean ± SE (n = 8–10 on each day) of the percentage when that of day 1 is assumed to be 100%. **p < 0.01, 
compared to sham-operated mice and ##p < 0.01, compared to non-induced MSC sheets transplanted 
mice, which were examined by ANOVA for repeated measurements. (b) Liver/body weight on day 8 
after transplantation are depicted in bars expressed as mean ± SE (n = 7–9 except n = 3 for CCl4(− )). 
**p < 0.01, compared with sham-operated mice (Games-Howell test). (c) Serum ALT on day 2, 4, and 8 after 
transplantation. (d) Serum AST on day 2, 4, and 8 after transplantation. Data are expressed as mean ± SE 
(n = 8–10 on each day). *p < 0.05, **p < 0.01, compared with sham-operated mice and #p < 0.05, compared 
with non-induced MSC sheets transplantation (Games-Howell test). (e) Total bilirubin on day 2. Data are 
expressed as mean ± SE (n = 8–10 on each day). **P < 0.01, compared with sham-operated mice (Games-
Howell test).
www.nature.com/scientificreports/
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growth factors that drive cell cycle progression during liver regeneration28. Phospho-c-Met, the receptor 
of HGF, was not detected, however, the prominent increase in expression and phosphorylation of EGFR 
in hepatic cell sheets-transplanted liver was observed (Fig.  7b). Of ligands for EGFR, gene expression 
including TGFα , EGF, HB-EGF, and amphiregulin29,30, was not altered between experimental groups 
(Supplementary Fig. 10), suggesting that EGFR signaling is activated by EGFR ligands derived from 
cell sheets. Human-specific gene expression including TGFα and amphiregulin was observed (Fig. 7a). 
Figure 6. Complement C3 activated IL-6/STAT-3 pathway through C5 followed by NF-κB activation. 
(a) Human-specific gene expression of hepatic origin. Expression of genes in cell sheets was assessed by 
RT-PCR analysis. All PCR procedures except for mouse β -actin were performed using primers specific for 
human mRNA transcripts. (b) Western blot of native liver tissues excluding grafted cell sheets. C5a was 
abundant in cell sheets transplanted native liver on day2 and 4. C5aR was not altered between experimental 
groups. Liver lysates of two mice from each group are used on each day. (c) Nuclear localization of 
NF-κ B. NF-κ B was detected in hepatocytes of native liver tissues transplanted cell sheets on day 2 by 
immunohistochemistry. Scale bar = 20 μ m. Sham and 3-layered sheets represent sham-operated group 
without cell sheets transplantation and 3-layered cell sheets derived hexachlorophene-induced MSCs 
transplanted group, respectively. (d) The NF-κ B-positive nuclei on day 2 (n = 6, 10 fields per each mice 
were measured). **p < 0.01 (Mann-Whitney U-test). (e) mRNA expression of murine IL-6 in murine liver 
tissue excluding grafted cell sheets measured by real-time PCR analysis. Bar expressed as mean ± SE (n = 6). 
*p < 0.05, examined by Mann-Whitney U-test. (f) Activation of STAT-3 pathway examined by western blot. 
Liver lysates without grafted tissues of two mice from each group were used on each day.
www.nature.com/scientificreports/
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Although TGFα was expressed equally on day 2 and 3, expression of amphiregulin reached its peak on 
day 3 (Fig. 7a), suggesting that amphiregulin is a more plausible agonist than TGFα . Since angiogenesis 
in necrotic area was significantly increased in transplanted tissues on day 4 (Fig. 7c,d), angiogenic fac-
tors including EGFα , angiopoietin, and angiogenin may play a role in this process (Fig. 7a). These data 
suggest that several cytokines play a role in the promotion of liver regeneration.
Transplantation of hepatic cell sheets reduced oxidative stress. To comprehensively explore 
further effects of cell sheets transplantation, proteomics analysis using mass spectrometry was per-
formed. Protein expression was compared between 3-layered cell sheets transplanted and sham-operated 
livers. Expression of 883 proteins was different between two groups by at least one-pair of comparative 
analysis (Supplementary Table 1). Ontological analysis revealed that oxidation reduction was significantly 
picked up by variations of 74 protein expression (Fig.  8a and Supplementary Table 2). Most of them 
were declined in transplanted livers on day 2, however, redox proteins including thioredoxin, peroxire-
doxin, and glutaredoxin31, exhibited higher expression in transplanted livers than sham-operated livers 
(Supplementary Table 2). Hence, dynamically altered protein expression involved in redox state was 
examined. 8-OHdG was intensely stained in sham-operated mice livers, however, it was significantly 
reduced in transplanted mice at day 2 and 3 (Fig.  8b,c). MDA adducts were also significantly reduced 
in transplanted mice compared to sham-operated mice on day 2 (Fig. 8d). The reduction of thioredoxin 
and peroxiredoxin, which was induced by liver injury, was interrupted by transplantation of cell sheets 
Figure 7. EGFR ligands secreted from grafted cell sheets involved in the phosphorylation of EGFR.  
(a) Human-specific gene expression analysis of cytokines in grafted tissues including cell sheets by RT-PCR 
analysis. All PCR procedures except for mouse β -actin were performed using primers specific for human 
mRNA transcripts. (b) Downstream signals of cytokines. Western blot was performed by using native liver 
lysates. (c) New vessels in necrotic area of native livers were determined by immunohistochemistry of CD31 
on day 4. Sham and 3-layered sheets represent sham-operated group without cell sheets transplantation 
and 3-layered cell sheets derived hexachlorophene-induced MSCs transplanted group, respectively. (d) The 
number of new vessels in necrotic area was expressed as mean ± SE (n = 6, 10 fields of individual mice were 
counted). **p < 0.01, examined by Mann-Whitney U-test.
www.nature.com/scientificreports/
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Figure 8. Redox state of cell sheets-transplanted murine liver. (a) GO classification. The percentages of 
coverage representing the percentage of proteins annotated with a specific GO term related to Biological 
Processes are shown (p < 0.001). GO annotation was performed with more than two-fold alterations in 
protein expression between the experimental groups. (b) Immunohistochemical analysis of 8-OHdG in 
native livers. Scale bar = 20 μ m. Sham and 3-layered sheets represent sham-operated group without cell 
sheets transplantation and 3-layered cell sheets derived hexachlorophene-induced BM-MSCs transplanted 
group, respectively. (c) The percentages for 8-OHdG-positive cells were expressed as mean ± SE (n = 6, 5 
fields of individual mice were counted). *p < 0.05, **p < 0.01, examined by Mann-Whitney U-test. (d) MDA 
adducts of murine liver tissues excluding grafted cell sheets. MDA adducts were measured by MDA ELISA 
analysis. The columns were expressed as mean ± SE (n = 3). *p < 0.05, examined by Mann-Whitney U-test. 
(e) Expression of proteins concerning thioredoxin reduction and oxidation cycle and catalase and SOD in 
Western blotting. Native liver lysates excluding grafted cell sheets were analyzed.
www.nature.com/scientificreports/
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on day 2 and 3. Thioredoxin reductase was also upregulated in cell sheets-transplanted mice on day 2 
(Fig.  8e). These data suggest that activation of thioredoxin oxidation and reduction cycle contributed 
to redox state in transplanted mice. Although SOD and catalase have been reported to affect the redox 
state after transplantation of MSCs2,32,33, decreased catalase and increased SOD was observed in trans-
plantated mice on day 2 (Fig. 8e). Although glutathione peroxidase and glutathione reductase were not 
altered between experimental groups, however, GSSG/GSH was higher in transplanted group on day 2 
(Supplementary Fig.11a,b). This may be partly because excess GSSG led to activation glutaredoxin31. 
These data suggest that thioredoxin oxidation and reduction cycle plays a key role in antioxidative effect 
of cell sheet therapy34. The other antioxidative proteins such as metallothionein35, fatty acid binding 
protein36, and apoptosis inducing factor 137 were also picked up by proteomics analysis. Taken together, 
these data suggest that the mechanisms of liver regeneration in the hepatic cell sheets transplantation 
system is proposed in Fig. 9.
Discussion
Several studies reported that MSCs were transdifferentiated into hepatocytes6,10,15,16, and intrasplenic or 
intravenous injection of hepatic differentiated MSCs ameliorated liver injury in mice2,8. MSCs are have 
beneficial effects in treatment of acute liver failure and cirrhosis13. However, transplantation of MSCs 
through portal vein is far from safe because of the risk of thromboembolism. In the present study, we 
developed a novel therapy system, in which cell sheets generated from MSCs by temperature-responsive 
polymer-coated dishes in the presence of a Wnt/β -catenin signal inhibitor were transplanted onto the sur-
face of liver. This procedure dramatically ameliorated liver injury in cell sheet number-dependent man-
ner. Survival rate of the mice receiving this therapy was significantly better than that of sham-operated 
mice. The present study showed that complement C3 is important for accelerating liver regeneration as 
well as antioxidative properties which MSCs originally harbor2,30,32.
Since it is well known that the mice which lack CYP2E1 expression are resistant to CCl4 since CYP2E1 
is responsible for bioactivation of CCl438. CYP2E1 expression was examined by using the mouse liver 
on 1 day after transplantation of cell sheets without CCl4 intoxication (designated 0 h in Supplementary 
Fig. 12a) and at 12 h after administration of CCl4 (Supplementary Fig. 12a). CYP2E1 expression was 
not different between sham-operated and cell sheets transplanted mice at 0 h and 12 h, suggesting that 
CYP2E1 expression which is responsible for bioactivation of CCl4, is not influenced by transplantation 
of cell sheets. As a result, there were no changes in ALT and AST at 0 h and 12 h after transplantation 
(Supplementary Fig. 12b,c).
Strategies of hepatic differentiation of MSCs have been limited to treatment with cytokines6,10,15,16. 
Since small molecule compounds are more safe and stable than nucleic acids and protein products, they 
are easily applicable for clinical settings39. This procedure highlighted a single compound instead of 
various cytokines. Although the reason why suppression of Wnt/β -catenin pathway induces hepatic dif-
ferentiation of MSCs remains to be clarified, a strong hint comes from the fact that β -catenin expression 
must be suppressed during the competence and specification stage in order for normal liver develop-
ment to occur40,41. Wnt/β -catenin signaling has been demonstrated to maintain stemness42. Endodermal 
differentiation is induced by high level of activin/Nodal signals. An endoderm progenitor including 
hepatic population was generated by culturing ES cells with activin, BMP-4, and FGF-443. Inhibition of 
Figure 9. Proposed mechanisms of liver regeneration in the hepatic cell sheets transplantation system. 
Complement C3 derived from human hepatic cell sheets activates NF-κ B via complement C5 resulted 
in nuclear translocation of NF-κ B of hepatocytes. Thioredoxin also activates NF-κ B through deoxidizing 
NF-κ B, by which in turn thioredoxin is oxidized. Thioredoxin is involved in redox system accompanied by 
thioredoxin reductase and peroxiredoxin. Nuclear localized NF-κ B upregulates transcriptional activity of 
IL-6, resulting in activation of IL6/STAT3 pathway and allowing hepatocytes to enter cell cycle. Activation of 
EGFR pathway is also involved in promoting cell growth.
www.nature.com/scientificreports/
13Scientific RepoRts | 5:16169 | DOi: 10.1038/srep16169
Wnt/β -catenin signaling suppresses expression of BAMBI, BMP and activin membrane-bound inhibi-
tor44. From these findings, suppression of Wnt/β -catenin signaling is associated with induction of activin/
Nodal signaling caused by inhibition of BAMBI.
In the present study, orthotopic transplantation of hepatic cell sheets accelerated liver regeneration 
in mice. These effects were superior to transplantation of non-differentiated MSC cell sheets. In the 
grafted tissues, complement C3/C5a/C5aR pathway was activated followed by nuclear translocation of 
NF-κ B of hepatocytes, resulting in enhanced IL-6 expression in hepatocytes. Interestingly, IL-6 expres-
sion was enhanced especially beneath the cell sheets, similarly to observed Ki-67-positive hepatocytes 
on day 2. C3, C5 and IL-6 were involved in promoting cell cycle from G0 to G127,45. Further progression 
of cell cycle could be partly promoted by EGFR phosphorylation through cell sheets-derived EGFR 
ligands. Another possible contribution to the liver regeneration could be antioxidant properties of the 
cell sheets. Transplantation of hepatic cell sheets reduced reactive oxygen species (ROS) of recipient 
livers. Thioredoxin has another important molecular function, which regulates activity of a series of 
transcription factors including NF-κ B31,46. Prominent NF-κ B nuclear localization on 2 days was proba-
bly regulated by thioredoxin. Moreover, in Figs 6b,f, 7b and 8e, the western blot analysis of C5a, C5aR, 
STAT3, EGFR, and oxidative stress-related proteins was performed by using the same liver lobe of the 
grafted cell sheets. However, overexpression and/or activation of these proteins was not observed when 
the different lobe from the grafted lobe of cell sheets was used as the sample of western blotting. These 
data suggest that the effects of hepatic cell sheets transplantation are associated with the distance from 
transplanted cell sheets.
We identified hexachlorophene as a Wnt/β -catenin signal inhibitor for human BM-MSC UE7T-13 
cells. Hexachlorophene was used as an antiseptic and was reported to be toxic47. However, our strategy to 
use hexachlorophene as an inducer of hepatic differentiation of cell sheets is safe due to the following rea-
sons. First, 3% (73.7 mM) hexachlorophene was used as an antiseptic. We used 0.8 μ M hexachlorophene, 
which is 92,125-fold lower than the concentration used as an antiseptic. Indeed, 0.8 μ M hexachlorophene 
has little effect on cell viability, as shown by WST assay (Supplementary Fig. 2). Second, hexachloro-
phene was thoroughly removed by washing twice with hexachlorophene-free medium. Therefore, hex-
achlorophene should be undetectable in cell sheets, and cell sheets should be absolutely safe since they 
contain little hexachlorophene. However, further efforts to identify more effective and safer compounds 
are required to open a way to clinical application.
In the present study, we demonstrated that human mesenchymal stem cell-engineered hepatic cell 
sheets have therapeutic effects on acute liver injury as well as preventive effects (Fig. 3). In addition, we 
found that human bone marrow cells from a patient with osteoarthritis gained liver functions such as gly-
cogen synthesis and urea production by treatment of hexachlorophene for 8 days (Supplementary Fig. 4). 
These data suggest that human BM-MSC-engineered hepatic cell sheets can be applicable for acute liver 
diseases in clinical settings. In addition, a novel approach in cell sheets technology using hepatocytes and 
fibroblasts has been reported to be useful as therapy of liver injury48,49. Since these cell sheets technolo-
gies have advantages of rapid fabrication and high vascularization, in combination with these excellent 
technologies, human BM-MSC-engineered hepatic cell sheets hopefully will become promising therapy 
for liver disease.
In conclusion, we developed a new therapy system for acute liver injury as an alternative therapy to 
liver transplantation, in which hepatic cell sheets derived from BM-MSCs served as cell therapy.
Methods
Chemicals and cells. Hexachlorophene, quercetin, CGP049090 and PKF115-584 were obtained from 
Sigma-Aldrich (St. Louis, MO). Ionomycin was obtained from Calbiochem (La Jolla, CA). Imatinib was 
purchased from Novartis International AG (Basel, Switzerland). PNU-74654, ICG-001, PKF118-310, and 
NSC668036 were synthesized in house. For all experiments, compounds were fleshly prepared by being 
dissolved in dimethyl sulfoxide (DMSO) or dH2O shortly prior to the experiment. The final concentra-
tion of DMSO in each experiment was 0.1%. UE7T-13 cells, human bone-marrow derived mesenchy-
mal stem cell line50, were used. Maintenance and differentiation medium was used DMEM (NICHIREI 
BIOSCIENCES INC., Tokyo, Japan) containing 10% fetal bovine serum (Nichirei), 100 U/ml penicillin, 
and 100 μ g/ml streptomycin.
Cell viability assay. At 24 h after seeding of UE7T-13 cells at density of 9.0 × 103 cells/cm2, various 
concentrations of compounds were added. Cell viability was assessed at 0, 2, 4, and 8 days with the use 
of cell counting kit (DOJINDO LABORATORIES. Kumamoto, Japan).
Establishment of TCF-4 motif-responsive luciferase stable cell line in UE7T-13 cells. The 
construct which contains three copies of the optimal TCF-4 motif CCTTTGATC upstream of the 
cytomegalovirus (CMV) promoter was inserted into multiple cloning sites of pGL4.20 firefly luciferase 
reporter plasmid (Promega Corp., Fitchburg, WI), and was designated pTCF4-CMVpro-GL4.20. UE7T-
13 cells were stably transfected with the linearized pTCF4-CMVpro-GL4.20 by electroporation and the 
puromycin-resistant clone was designated E7-TCF4.
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Reporter assay. At 24 h after seeding of E7-TCF4 cells at density of 9.0 × 103 cells/cm2, various con-
centrations of compounds were added. At 1, 4, and 8 days after addition, reporter assay was performed 
with Luciferase assay system (Promega Corp.) using plate reader (PerkinElmer, Inc., MA).
In vitro hepatic differentiation procedure of MSCs. UE7T-13 cells seeded at a density of 
9.0 × 103 cells/cm2 were cultured overnight to allow cell attachment. After the addition of each com-
pound, hepatic differentiation was performed for 8 days. Medium was changed on day5.
RNA extraction and reverse transcription- polymerase chain reaction (RT-PCR). Total RNA 
from the cells was extracted with TRIzol reagent (Life Technologies Corp., Carlsbad, CA) and sub-
jected to reverse transcription using Superscript II (Life Technologies Corp.) and oligo(dT)18 primers for 
in vitro assay and random hexamer for in vivo assay. RT-PCR was performed using gene specific primers 
and rTaq DNA polymerase (TOYOBO CO., Ltd. Osaka, Japan). Primer lists for RT-PCR analysis are 
indicated in Supplementary Tables 3–6.
Immunofluorescence analysis. At 8 days after incubation with compounds, the cells were fixed and 
performed immunofluorescence analysis as described previously51. Antibodies used in this study were as 
follows: anti-human serum albumin antibody (Sigma-Aldrich Corp.), and anti-human C/EBPα antibody 
(Santa Cruz Biotechnology, Inc., Santa Cruz, CA), and AlexaFluoro 594 goat anti-rabbit immunoglobulin 
G or AlexaFluoro 488 goat anti-mouse immunoglobulin G (Molecular Probes, Leiden, Netherlands). 
Nuclei were stained with 4′ ,6-diamidino-2-phenylindole (Sigma-Aldrich Corp.).
Periodic acid-Schiff staining for glycogen. UE7T-13 cells treated with the indicated compound for 
8 days were trypsinized and inoculated onto cover glasses. The cells were fixed in phosphate-buffered 
saline containing 4% paraformaldehyde. Periodic acid-Schiff (PAS) staining was performed as described 
previously14,15.
Urea Assay. At 8 days after cultivation with compounds, UE7T-13 cells were incubated in the media 
with 5 mM ammonium chloride, and the amount of urea secreted into the medium was measured 
according to the previous reports14,15.
Western blot analysis of cell lysates. Ten micrograms of the cell lysis proteins were subjected 
to western blot analysis. The rabbit polyclonal antibodies including anti–β -catenin (Cell Signaling 
Technology Inc.), mouse monoclonal antibodies including anti-cyclin D1 (Santa Cruz Biotechnology, 
Inc.), and goat polyclonal antibodies including anti-Actin (Santa Cruz Biotechnology, Inc.) were used. 
Actin was used as an internal control. The bands were detected by ImageQuant LAS4000 (GE Healthcare 
UK Ltd, Little Chalfont, UK).
Hepatic cell sheets by treating mesenchymal stem cells with hexachrolophene. Human 
UE7T-13 BM-MSCs were plated onto ϕ 60 mm-temperature-responsive culture dishes (CellSeed Inc., 
Tokyo, Japan) at a cell density of 9.0 × 103 cells/cm2 and incubated with 0.8 μ M hexachlorophene at a 
temperature of 37 °C. After incubation for 8 days, the cells were detached from the culture dishes as a 
cell sheet by incubating at a temperature of 20 °C for about 15 min. The cell sheets of non-differentiated 
MSCs were created by plating UE7T-13 cells at a cell density of 3.6 × 104 cells/cm2 and incubating them 
without hexachlorophene at a temperature of 37 °C for 4 days.
Animal experiments. All animal experiments were performed with the approval of the Tottori 
University Subcommittee on Laboratory Animal Care, and carried out in accordance with the approved 
guidelines. Eight to nine-weeks-old nonobese diabetic severe combined immunodeficient (NOD-SCID) 
mice were purchased from CLEA Japan (Tokyo, Japan). The mice had free access to food and water, and 
were housed under pathogen-free conditions in a temperature-controlled room and illuminated 12 h 
daily. The cell sheets were transplanted onto two sites of liver surface of each mouse. The additional cell 
sheets were overlaid one by one on the pre-existing cell sheets. The 1-, 2-, and 3-layered cell sheets trans-
plantation group represent the mice which received 1-, 2-, and 3-layered cell sheets, respectively. Control 
mice were operated sham laparotomy. The cell sheets of UE7T-13 BM-MSCs without treatment with 
hexachlorophene were also transplanted onto two sites of left lateral lobe of liver in a manner of 3-layered 
cell sheets. On 1 day after transplantation, all the groups were administrated 0.2 ml/kg of carbon tetra-
chloride (Wako Pure Chemical Industries Ltd., Osaka, Japan) dissolved in olive oil at 5% concentration 
by oral gavage. On 2 and 4 days after transplantation, blood samples were collected from retro-orbital 
venous plexus under isoflurane (AbbVie Inc. Tokyo, Japan) anesthesia. On 8 days after transplantation, 
mice were sacrificed by exsanguination under anesthetized with pentobarbital sodium and blood samples 
were collected from inferior vena cava. Collected blood were kept on ice overnight, and then centrifuged 
at 2,000 g for 20 min at 4 °C. To examine therapeutic mechanisms, 3-layered cell sheets transplanted mice 
and sham-operated mice were sacrificed on day 1, day 1.5 in addition to day 2, 3, and 4. Liver tissues 
were dissected and weighed wet volume.
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The therapeutic effects of hepatic cell sheets on acute liver injury was assessed as follows. Eight to 
nine-weeks-old NOD-SCID mice were administered 0.2 ml/kg of carbon tetrachloride (Wako Pure 
Chemical Industries Ltd., Osaka, Japan) dissolved in olive oil at 5% concentration. At 6 h after oral 
administration of CCl4, 3-layered cell sheets were transplanted on two sites of the mouse liver surface. 
The sham-operated mice without transplantation of cell sheets were used as controls. On 1, 2, and 3 days 
after CCl4 administration, the mice were sacrificed and blood samples were collected for measurement 
of ALT, AST and total bilirubin.
Biochemical tests. Serum aminotransferases were measured by Transaminase CII-test Wako (Wako 
Pure Chemical Industries Ltd.) according to the manufacture’s protocol. Serum bilirubin was measured 
by QuantiChrom™ Bilirubin Assay Kit (BioAssay Systems LLC, Hayward, CA). Both absorbance was 
measured using plate reader (Tecan Japan Co., Ltd., Kanagawa, Japan).
Histology. Liver tissues containing the cell sheets were fixed in 4% parafolmaldehyde and 
paraffin-embedded. 3 μ m thick slice was used for H&E staining according to standard methodology. The 
necrotic area was measured by ImageJ software (http://imagej.nih.gov/ij/).
Immunohistochemistry. 3-μ m thick sections were examined using immunohistochemistry. The sec-
tions were deparaffinized, and antigens were retrieved by autoclave in citrate buffer or protease for 30 min 
at 37 °C. Endogenous peroxidase activity was blocked by immersing the slides in 3% hydrogen peroxide 
in methanol for 15 min except for 8-OHdG staining. The sections were immunostained using a Histofine 
mouse stain kit (NICHIREI BIOSCIENCES INC.) for mouse monoclonal primary antibodies including 
anti-8-OHdG (Japan Institute for the Control of Aging, Nikken SEIL CO., Lte., Shizuoka, Japan) and 
anti-NF-κ B (Santa Cruz Biotechnology, Inc., Santa Cruz, CA). Hsitofine Simple Stain™ Mouse MAX PO 
(Rat) was used for rat primary antibody, anti-Ki-67 (DakoCytomation, Glostrup, Denmark). Histofine 
Simple Stain™ Mouse MAX PO (G) was used for goat primary antibody, anti-CD31 (BD Biosciences, 
San Jose, CA, USA). Histofine Simple Stain™ Mouse MAX PO (R) (NICHIREI BIOSCIENCES INC.) for 
rabbit polyclonal IL-6 antibody (Abcam Ltd., Cambridge, UK). Positive cells for 8-OHdG and Ki-67 were 
counted automatically by inForm, advanced image analysis software (PerkinElmer, Massachusetts, USA).
Western blot analysis of liver tissue lysates. Ten to thirty micrograms of the tissue lysis pro-
teins not including grafted cell sheets or including cell sheets were subjected to western blot analysis. 
Antibodies used in this experiment as follow: anti-C5aR, IL-6, Glutatione peroxidase 1, Glutathione 
reductase, catalase (Abcam Ltd.), anti-C5a, c-kit, SOD1 (Santa Cruz Biotechnology, Inc.), anti-TRXR1, 
EGFR, phospho-EGFR, phosphor-c-kit, STAT3, phosphor-Stat3 (Cell Signaling Technology Inc.), 
anti-peroxiredoxin 2 (Sigma-Aldrich Corp.), and goat polyclonal antibodies including anti-Actin (Santa 
Cruz Biotechnology, Inc.). Actin was used as an internal control. The bands were detected by ImageQuant 
LAS4000 (GE Healthcare UK Ltd.).
Oxidative stress analysis. MDA adduct content was measured by OxiSelect™ MDA Adduct ELISA 
Kit (Cell Biolabs, Inc., San Diego, CA) according to the manufacture’s instructions. GSSG/GSH was 
measured by GSSG/GSH Quantification Kit (DOJINDO LABORATORIES, Kumamoto, Japan) according 
to manufacture’s protocols. Absorbance was measured using plate reader (Tecan Japan Co., Ltd.).
Quantitative RT-PCR analysis. cDNA was synthesized by reverse transcription using Superscript II 
(Life Technologies Corp.) and oligo (dT)18 primers. Real-time RT-PCR was performed using LightCycler® 
FastStart DNA Master SYBR Green I (Roche Diagnostics GmbH., Mannheim, Germany). PCR run 
was performed in LightCycler system (Roche Diagnostics GmbH.). Primers for real-time RT-PCR 
analysis are as follows: murine IL6-Forward, 5′ - acctggagtacatgaagaacaactt -3′ ; murine IL6-Reverse, 
5′ -ggaaattggggtaggaagga -3′ , mβ -actin-Forward, 5′ -agagcaagagaggtatcctg -3′ ; mβ -actin-Reverse, 
5′ -agagcatagccctcgtagat -3′ .
Proteome analysis. The tissues were frozen in liquid nitrogen and then disrupted with Multi-beads 
shocker (MB400U, Yasuikikai). The disrupted cells were suspended with 0.1 M Tris-HCl (pH 9.0), con-
taining protease inhibitors cocktail (SIGMA-Aldrich). The homogenate was centrifuged at 1,500 g for 
10 min. The supernatant was collected and urea was added to a final concentration of 8 M. The solution 
was reduced with dithiothreitol, alkylated with iodoacetamide, and then digested with Lys-C (WAKO) 
followed by dilution and digestion with sequence grade modified trypsin (Promega). After digestion, the 
samples were desalted with StageTip52 using SDB-XC disk membrane (3 M). The desalted peptides were 
labeled with differential stable isotopes in samples for relative protein quantification by using dimethyl 
labeling method53. The labeled peptides were desalted as mentioned above and analyzed by nanoLC-MS/
MS analysis using LTQ-Orbitrap XL (Thermo Fisher Scientific) in accordance with a previous report54. 
Peptides and proteins were identified by means of automated data base searching using Mascot version 
2.3 (Matrix Science, London, UK) against UniProt/SwissProt release 2012_02× with a precursor mass 
tolerance of 3 ppm, a fragment ion mass tolerance of 0.8 Da, and strict trypsin specificity allowing for up 
to two missed cleavages. Cysteine carbamidomethylation was set as a fixed modification, and methionine 
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oxidation and [1H4,12C2] or [2H4,13C2]-dimethylation of N-terminal and lysine ɛ -amino groups were 
allowed as variable modifications. Peptides were considered identified if the Mascot score was over the 
95% confidence limit based on the “identity” score of each peptide. Proteins showing altered expression 
with fold change values of ≥ 2.0 between the groups were exported for functional annotation to The 
Database for Annotation, Visualization and Integrated Discovery (DAVID).
Statistical Analysis. All the values in the present study were expressed as mean ± SE. The significant 
differences between the groups were analyzed by a Student’s t test or a Mann–Whitney U test and a 
Games Howell test. The significance of survival was analyzed by a Log-rank test. All statistical analysis 
was performed using predictive analytics software (SPSS Inc., Chicago, IL, USA). A P-value less than 
0.05 was considered to be significant.
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